Press Releases | Medtronic

Month Year

Email alerts

Feb 20, 2018

Medtronic Reports Third Quarter Financial Results

Revenue of $7.4 Billion Increased 1% as Reported; 7% at Comparable, Constant Currency

DUBLIN - February 20, 2108 - Medtronic plc (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2018, which ended January 26, 2018. The company reported third quarter...
Feb 16, 2018

Medtronic Chairman and CEO Omar Ishrak to Speak at CEO Investor Forum 3.0

DUBLIN - February 16, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the CECP CEO Investor Forum 3.0 in New York on Monday,...
Feb 15, 2018

New Pediatric At-Home Study of MiniMed(TM) 670G System Demonstrates Positive Results in Children Ages 7 to 13

DUBLIN and VIENNA - February 15, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that new data from its at-home pediatric study of the MiniMed(TM) 670G...
Feb 13, 2018

Medtronic Announces Upcoming Data Presentations at the Advanced Technologies and Treatments for Diabetes 11th International Conference

Medtronic Will Host an Exclusive Symposium on Thursday, February 15

VIENNA - February 13, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its schedule of notable sessions that will be presented at the Advanced Technologies...
Feb 13, 2018

Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2018

DUBLIN - February 13, 2018 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for the third quarter of fiscal year 2018 on Tuesday, February 20, 2018. A news release...
Jan 30, 2018

IN.PACT Admiral Demonstrates Consistent and Durable Outcomes in New Two-Year Japan Data and IN.PACT Global Critical Limb Ischemia Cohort Analysis

Data Presented at LINC 2018 Highlight IN.PACT Admiral as Safe and Effective Treatment Option in PAD

DUBLIN and LEIPZIG - January 30, 2018 - Medtronic plc (NYSE: MDT) today added to its robust body of clinical evidence supporting the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) with new...
Jan 30, 2018

Medtronic and Philips Partner to Innovate in Lung Cancer Management

Healthcare Leaders Join to Streamline and Optimize the Management of Lung Nodules

DUBLIN and AMSTERDAM - January 30, 2018 - In a collective effort to improve the management of patients with lung nodules, Medtronic plc (NYSE: MDT) and Royal Philips (NYSE: PHG; AEX: PHIA) have...
Jan 30, 2018

Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region

DUBLIN and SHANGHAI - January 30, 2018 - Medtronic plc (NYSE:MDT) today announced that Alex Gu, previously Vice President, Regional Growth Initiatives, Greater China, and leader of Medtronic's...
Jan 26, 2018

Medtronic Launches IDE Study to Evaluate the Abre(TM) Venous Self-Expanding Stent System in Patients with Deep Venous Disease

Study to Enroll Subjects at up to 35 Sites Across the U.S. and Europe

DUBLIN - January 26, 2018 - Medtronic plc (NYSE: MDT) today announced the initiation of its investigational device exemption (IDE) study for the Abre(TM) venous self-expanding stent system. The...
Jan 24, 2018

Medtronic Launches ENCHANT Study to Evaluate ChEVAR Parallel Graft Technique with the Endurant(TM) II/IIs Stent Graft System

Clinical Study to Investigate the Performance of the ChEVAR Technique in AAA Patients with Short Aortic Necks

DUBLIN - January 24, 2018 - Medtronic plc (NYSE: MDT) today announced the launch of the ENCHANT (ENdurant CHEVAR New Indication Trial) study. The post-market, non-interventional, multi-center,...

Show per page